The CGCS Awards ceremony was held at the 5th International Cell & Gene Therapy China Summit & Exhibition 2024. Jiangsu Celltech Medical Research Institute won the "Cell Therapy R&D" Rising Star Award at the ceremony!

Medical enterprises jointly build a scientific innovation platform——Jiangsu Celltech Medical Research Institute signed a scientific research cooperation agreement with Taizhou Second People's Hospital

From May 22nd to 24th, 2024, the 5th International Cell and Gene Therapy China Summit & Exhibition (CGCS 2024) was grandly held at Nanjing Yangtze River International Conference Center. Professor Yang Meijia of Jiangsu Celltech Medical Research Institute was invited to attend the CGCS summit as a major guest of the main forum.

Recently, the Jiangsu Provincial Department of Human Resources and Social Security announced the "List of New Postdoctoral Innovation Practice Bases in Jiangsu Province in 2022-2023", and Jiangsu Celltech Medical Research Institute was approved as the "Postdoctoral Innovation Practice Base in Jiangsu Province".

On February 29, the Jiangsu Provincial Department of Industry and Information Technology held a special event for the upstream and downstream docking of the gene and cell therapy industry chain in Jiangning District, Nanjing. Representatives from the Provincial Department of Industry and Information Technology, the Provincial Food and Drug Administration, the Municipal Bureau of Industry and Information Technology, the Jiangning District Bureau of Industry and Information Technology, and representatives from Jinsirui Biotech, Chuanqi Biotech, , Nanjing EnruiKainuo Biotech, Nanjing Rongjiekang Biotech, Heqirui Pharmaceutical, Yingshi Biotech and other enterprises attended the event.

At the beginning of January 2024, Nanjing TV interviewed , Executive Vice President Liu Yongjun said: I believe that the innovation environment in Nanjing will get better and better in the future, and I am full of confidence in the future development.